Rapport Therapeutics (RAPP) Times Interest Earned (2023 - 2026)
Rapport Therapeutics' (RAPP) quarterly Times Interest Earned came in at -$0.2 in Q1 2026, down 8689.82% year-on-year from $0.0 in Q1 2025, and up 42.19% on a QoQ basis from -$0.34 in Q4 2025.
Rapport Therapeutics (RAPP) Times Interest Earned (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Times Interest Earned data on file, last reported at -$0.2 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 8689.82% year-over-year to -$0.2 in Q1 2026; TTM through Mar 2026 was -$0.99, a 12820.53% decrease from a year earlier, with the FY2025 full-year figure at -$1.1, up 54.59% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.2, up from -$0.34 in the prior quarter.
- Over the last five years, Times Interest Earned for RAPP reached as high as -$0.0 in Q1 2025 and fell as low as -$1.76 in Q2 2025.
- Historically, Times Interest Earned has averaged -$0.59 across 4 years, with a median of -$0.43 in 2024.
- Across the five-year window, Times Interest Earned soared 50.64% in 2025 and tumbled 8689.82% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$1.13 in 2023, then surged by 39.11% to -$0.69 in 2024, then surged by 50.64% to -$0.34 in 2025, then surged by 42.19% to -$0.2 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.2 in Q1 2026, -$0.34 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Rapport Therapeutics | 1.94 Bn | 1.94 Bn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -1.76 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.69 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | -0.37 |
| Dec 31, 2023 | -1.13 |
| Jun 30, 2023 | -0.69 |